Maximilian Alexander Rohnert^1*, Jonas Schadt^1*, Michael Kramer^2*, Christoph Röllig^1*, Johannes Schetelig, MD, MSc^3,4, Friedrich Stölzel^5*, Désirée Kunadt^6*, Jan Moritz Middeke, MD^6*, Lars Thielecke^7*, Friedemann Uschner^7*, Ingmar Glauche^7*, Christian Thiede^1,8*, Martin Bornhaeuser, MD⁹, Uta Oelschlaegel^1*, Malte von Bonin, MD^10*, Uwe Platzbecker, MD¹¹, Claudia D Baldus, MD^12*, Hubert Serve, MD¹³ and Carsten Mueller-Tidow, MD^14*

¹University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany
²AvenCell Europe GmbH, Dresden, Germany
³Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
⁴DKMS Group gGmbH, Dresden, Germany
⁵Division of Stem Cell Transplantation and Cellular Immunotherapies, University Hospital Schleswig-Holstein, Kiel, Germany
⁶Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
⁷Institute for Medical Informatics and Biometry (IMB), Faculty of Medicine, TU Dresden, Dresden, Germany
⁸AgenDix GmbH, Dresden, Germany
⁹Department of Internal Medicine I, Universitatsklinikum Cad GustavCarus an der Technischen Universltat Dresden, Dresden, Ferscherstrabo 74, Germany
¹⁰University Hospital Carl Gustav Carus Technical University Dresden, Dresden, Germany
¹¹Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
¹²University Medical Center Schleswig-Holstein, University Cancer Center Schleswig-Holstein, Kiel, Germany
¹³Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany
¹⁴Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany

Johann K. Hitzler, MD¹, Todd A. Alonzo, PhD^2*, Robert Gerbing, MS^3*, Jim Wang, MS^2*, Amy Beckman, MD^4*, Betsy Hirsch, PhD^5*, Susana C. Raimondi, PhD^6*, Karen M Chisholm, MD, PhD⁷, Shelton A. Viola, MD^8*, Anupam Verma, MD^9*, Lisa Eidenschink Brodersen, PhD^10*, Michael R. Loken, PhD^11*, Jeffrey W. Taub, MD¹², Alan S Gamis, MD, MPH¹³, E. Anders Kolb, MD¹⁴, Todd M Cooper, DO¹⁵ and Jason N. Berman, MD¹⁶

¹Division Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, CAN
²Children's Oncology Group, Monrovia, CA
³Children's Oncology Group, Arcadia, CA
⁴Division of Laboratory Medicine, University of Minnesota, Minneapolis, MN
⁵University of Minnesota, Minneapolis, MN
⁶St. Jude Children's Rsch. Hosp., Memphis, TN
⁷University of Washington, Seattle, WA
⁸Naval Medical Center- Portsmouth, Portsmouth, VA
⁹Inova Fairfax Hospital, Fairfax, VA
¹⁰Children's Hospital of Philadelphia, Philadelphia, PA
¹¹Hematologics, Inc., Seattle, WA
¹²Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI
¹³Hematology/Oncology/BMT, Children's Mercy Kansas City, Kansas City, MO
¹⁴Leukemia & Lymphoma Society, Bronx, NY
¹⁵Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Childrens Hospital, Seattle, WA
¹⁶CHEO Research Institute, Ottawa, ON, CAN

Rasha W Al-Ali^1*, Gege Gui^1*, Niveditha Ravindra, MD^2*, Georgia Andrew, BSc^2*, Devdeep Mukherjee, PhD^2*, Zoë Wong, BSc^2*, Ying Huang, PhD^3*, Jason Gerhold^4*, Matthew Holman, BSc^3*, Austin Jacobsen^5*, Julian D'Angelo^5*, Jeffrey E Miller, PhD³, Karina Elias^5*, Jeffery J. Auletta, MD⁶, Firas El Chaer, MD^7*, Steven Michael Devine, MD⁸, Antonio M. Jimenez Jimenez, MD, MSc^9*, Marcos de Lima^10*, Mark R. Litzow, MD¹¹, Partow Kebriaei, MD¹², Wael Saber, MD, MS^13,14, Stephen R. Spellman^6*, Scott L. Zeger, PhD^15*, Kristin Page¹⁶, Coleman Lindsley, MD, PhD¹⁷, Jerald P. Radich, MD¹⁸, Christopher S. Hourigan, DM, DPhil^1,2 and Laura W Dillon, PhD^2*

¹Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC
²Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, MD
³Invivoscribe, Inc., San Diego, CA
⁴VP, Global Regulatory, Quality, & Clinical Affairs, Invivoscribe, Inc., San Diego, CA
⁵Invivoscribe, Inc, San Diego, CA
⁶CIBMTR® (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN
⁷University of Virginia Health System, Charlottesville, VA
⁸Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN
⁹Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL
¹⁰Division of Hematology, The Ohio State University, Columbus, OH
¹¹Division of Hematology, Mayo Clinic, Rochester, MN
¹²M.D. Anderson Cancer Center, Houston, TX
¹³Center for International Blood and Marrow Transplant Research, Minneapolis, MN
¹⁴Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
¹⁵Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
¹⁶Medical College of Wisconsin, Milwaukee, WI
¹⁷Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁸Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Rsch. Ctr., Seattle, WA

Isabell Arnhardt^1*, Christian M. Vonk^2*, Xavier Cheng-Hong Tsai, MD, PhD³, Felicitas R. Thol, MD¹, Wen-Chien Chou, MD, PhD⁴, Hsin-An Hou, M.D.; Ph.D.³, Razif Gabdoulline^1*, Florian H. Heidel, MD⁵, Hwei-Fang Tien, MD, PhD⁶, Michael Heuser, MD^7,8 and Peter J. M. Valk, PhD²

¹Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
²Erasmus University Medical Center, Rotterdam, Netherlands
³Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
⁴Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan
⁵Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
⁶Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
⁷Department of Internal Medicine IV, Martin-Luther-University Halle-Wittenberg, Halle, Germany
⁸Department of Internal Medicine IV, University Hospital Halle (Saale), Halle (Saale), Germany

Luyang Zhang^1,2*, Ye Guo^3,4*, Wenyu Yang^4,5*, Xiaojuan Chen, MD^3,4*, Yumei Chen^3,4*, Li Zhang^4,5*, Yao Zou^4,6*, Xiaofan Zhu, MD^4,6 and Min Ruan, MD^2,7*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
²Chinese Academy of Medical Sciences Tianjin Institutes of Health Science, Tianjin, China
³Department of Pediatric Hematology and Oncology, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College, Tianjin, China
⁴Tianjin Institutes of Health Science, Tianjin, China
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College, Tianjin, China
⁶State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC, Tianjin, China
⁷State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China

Gojiri Mawalankar, MD^1*, Aarti Ramesh Achrekar, MSc^1*, Yamini G^1*, Bhagyashree Satam^1*, Sitaram Ghogale^1*, Nilesh Deshpande^1*, Dhanlaxmi Lalit Shetty, PhD, MSc^2,3*, Nishant Jindal, MD, MBBS^4,5*, Prashant Tembhare, MD^1,5*, Sumeet Mirgh, MD, DM^4,5*, Alok Shetty, MD, DM^6*, Anant Gokarn, MD, DM^5,7*, Sachin Punatar, MD, DM^5,7*, Lingaraj Nayak, MBBS, MD, DM^5,6*, Hasmukh Jain, MD, DM^5,8*, Manju Sengar, MD, DM⁸, Navin Khattry, MD, DM^4,5*, Bhausaheb Bagal, MD, DM^5,6*, Sweta Rajpal, MD, DM^1,5*, Gaurav Chatterjee, MD, MSc^1,5*, PG Subramanian, MD^1*, Sumeet Gujral, MD^9* and Nikhil Patkar, MD^1,5*

¹Department of Hematopathology, ACTREC, Tata Memorial Centre, Navi Mumbai, India
²Cancer Cytogenetics, ACTREC, Tata Memorial Centre, Navi Mumbai, India
³Tata Memorial Hospital, Mumbai, India
⁴Department of Medical Oncology, ACTREC, Tata Memorial Centre, Navi Mumbai, India
⁵Homi Bhabha National Institute, Mumbai, India
⁶Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
⁷Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India
⁸Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
⁹Department of Pathology, Tata Memorial Centre, Mumbai, India

Anastasia Soboli^1*, Anne Maria Tierens, MD, PhD², Leo Escano, BS^3*, Mathias Jerkfelt, MD^4*, Anna Rehammar, PhD^5*, Liv T. N. Osnes, MD, PhD^6*, Sanna Siitonen, MD, PhD^7*, Hanne Vibeke Marquart, MD, PhD^8*, Rock Yuk Yan Leung^9*, Helly Vernitsky^10*, Josefine Palle, MD, PhD^11*, Bernward Zeller, PhD^12*, Kirsi Jahnukainen^13*, Henrik Hasle¹⁴, Birgitte Lausen^15*, Daniel Cheuk^16*, Nira Arad-Cohen^17*, Florian Kuchenbauer, MD, PhD, FRCPC¹⁸, Jonas Abrahamsson, MD, PhD, Professor^19* and Linda Fogelstrand, MD¹

¹Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
²Laboratory Medicine Program, University Health Network, Toronto, ON, Canada
³Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, Canada
⁴Department of Medicine, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden
⁵School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
⁶Oslo University Hospital, Department of Immunology, Oslo, Norway, NOR
⁷Helsinki University Ctrl. Hospital, Helsinki, FIN
⁸Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark
⁹Department of Pathology, The University of Hong Kong, Hong Kong, Hong Kong
¹⁰Sheba Medical Center, Tel Hashomer, ISR
¹¹Department of Women´s and Children´s Health, Uppsala University, Uppsala, Sweden, Uppsala, Sweden
¹²Department of Pediatric Hematology-Oncology, Oslo University Hospital, Oslo, Norway
¹³New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
¹⁴Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
¹⁵Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Denmark, Copenhagen, Denmark
¹⁶Department of Pediatrics and Adolescent Medicine, Hong Kong Children's Hospital and Hong Kong Pediatric Hematology and Oncology Study Group (HKPHOSG), Hong Kong, China
¹⁷Department of Pediatric Hemato-Oncology, Rambam Health Care Campus, Haifa, Israel
¹⁸Department of Medicine, Division of Hematology, University of British Columbia, Leukemia Bone Marrow Transplant Program of British Columbia and Vancouver General Hospital, Vancouver, BC, Canada, Vancouver, BC, Canada
¹⁹Department of Pediatrics, Institution for Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Ruwan Gunaratne, MD, PhD^1,2, Crystal Zhou, BA^1*, Jesse W. Tai, MS, BS¹, Sky Kim, BS^1*, Kailee Tanaka, BA^1*, Sanjeeth Rajaram, BA^1*, Mia Carleton, BA^2*, Raymond Yin, MS^3*, Matthew Alkaitis, MD, PhD^4*, Matthew Schwede, MD⁵, Brian J. Sworder, MD, PhD^2,6, Michael S. Khodadoust, MD, PhD², Ravi Majeti, MD, PhD^1,7,8, David Kurtz, MD, PhD^1,2,8,9 and Tian Y Zhang, MD, PhD^1,8

¹Division of Hematology, Department of Medicine, Stanford University, Stanford, CA
²Division of Oncology, Department of Medicine, Stanford University, Stanford, CA
³University of California San Francisco, San Francisco, CA
⁴Department of Medicine, Stanford University, Stanford, CA
⁵Swedish Cancer Institute, Center for Blood Disorders and Stem Cell Transplantation, Seattle, WA
⁶Division of Hematology and Oncology, University of California, Irvine, Irvine, CA
⁷Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA
⁸Stanford Cancer Institute, Stanford, CA
⁹Foresight Diagnostics, Boulder, CO

Raphael Hablesreiter^1*, Paulina Strzelecka^1*, Natalia Estrada^1*, Klara Kopp^1*, Anna Dolnik^1*, Marlon Tilgner^1*, Coral Fustero^1*, Felicitas R Thol, MD², Florian H. Heidel, MD³, Michael Heuser, MD², Lars Bullinger^1,4, Friederike Christen^1* and Frederik Damm^1,4*

¹Department of Hematology, Oncology, and Cancer Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
²Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
³Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
⁴German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany